Journal profile · Pharmacology & Pharmacy
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
ISSN 1482-1826 · Canadian Society for Pharmaceutical Sciences · CANADA · Quarterly · Founded 1998
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 5.3; fully open access; APC about USD 2,200; median 96 days to acceptance (50 articles, last 24 months); community-reported acceptance: fairly easy; 21 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES is published by Canadian Society for Pharmaceutical Sciences and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Drug Transport and Resistance Mechanisms, Drug Solubulity and Delivery Systems and Pharmacogenetics and Drug Metabolism, together about 25.9% of its articles. Its main subfields are Pharmaceutical Science. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Pharmacy & Pharmaceutical Sciences (JPPS) (ISSN 1482-1826) is a broad-spectrum, peer-reviewed, international pharmaceutical journal. JPPS was the first open access journal in the field established in 1998 and aims to be the leading journal in the fields of pharmacy and pharmaceutical sciences by publishing open access premier research. JPPS is the official journal of the Canadian Society for Pharmaceutical Sciences (CSPS). The published archive of JPPS (volumes 1-10) can be found here.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editorial board by country: 1 in mainland China (about 2%); most named United States 19, Canada 16, United Kingdom 4, Mainland China 1, Australia 1 (42 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Drug Transport and Resistance MechanismsMedicine9%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics8.7%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics8.2%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics8.2%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics6.6%
- Computational Drug Discovery MethodsComputer Science5%
- Pharmaceutical studies and practicesMedicine4.2%
- Statistical Methods in Clinical TrialsMathematics3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPMCCAB AbstractsPublisher website
Other: Google Scholar, EBSCO, Dimensions, CNKI, Crossref, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.3LetPub ·
- Impact factor (publisher)
- 5.5Publisher website ·
- CiteScore 2026-06
- 8.8LetPub ·
- CiteScore (publisher)
- 8.8Publisher website ·
- SJR 2026-06
- 1.11LetPub ·
- SNIP 2026-06
- 1.23LetPub ·
- h-index
- 69LetPub ·
- h-index
- 69OpenAlex ·
- i10-index
- 522OpenAlex ·
- 2-year mean citedness
- 5.75OpenAlex ·
- Self-citation rate
- 1.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 18LetPub ·
Articles by year OpenAlex count · 834 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 29 | 29 | 21 |
| 2025 | 21 | 21 | 36 |
| 2024 | 34 | 34 | 426 |
| 2023 | 25 | 25 | 298 |
| 2022 | 29 | 29 | 649 |
| 2021 | 51 | 51 | 763 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
96 daysMedian, submission to acceptance · P25–P75 79 days – 134 days
- Acceptance to online
- median 15 days (50 articles)
- Submission to online
- median 119 days
- Sample
- 50 articles with submission and acceptance dates (52 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to publication (journal-reported)
- about 15 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,200 | Yes | CC BY | |
| OpenAlex | USD 2,200 | — | — | |
| LetPub | USD 2,450 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Keywords
- ≥ 5
- Reference style
- Vancouver
Policy excerpts from the journal's websiteConflicts of interest, Publication ethics, License & copyright, Open access
- Conflicts of interest
The journal participates in CrossMark to maintain published content and alert readers to changes. Model summary
CrossMark is a multi-publisher initiative to provide a standard way for readers to locate the current version of a piece of content. By applying the CrossMark logo the journal is committed to maintaining the content it publishes and to alerting readers to changes if and when they occur.
Source ↗Publisher website ·- Publication ethics Policies and publication ethics
All articles are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0).
Source ↗Publisher website ·- License & copyright 2.1. CC-BY Licence
All figures, tables, and images will be published under a Creative Commons CC-BY licence, and permission must be obtained for use of copyrighted material from other sources (including re-published/adapted/modified/partial figures and images from the internet). It is the responsibility of the authors to acquire the licenses, follow any citation instructions requested by third-party rights holders, …
Source ↗Publisher website ·- Open access Open Access Statement
The Journal of Pharmacy & Pharmaceutical Sciences provides online free gold open access to the journal and all of its research publications. Open Access funder and institutional mandates: The Journal of Pharmacy & Pharmaceutical Sciences is fully compliant with open access mandates, by publishing its articles under the Creative Commons Attribution licence (CC-BY). Funder mandates such as those by …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Canadian Society for Pharmaceutical Sciences
- Country or region
- CANADA
- Language
- English
- Frequency
- Quarterly
- Founded
- 1998
- ISSN
- 1482-1826
- Society / sponsor
- Canadian Society for Pharmaceutical Sciences
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
What CAS zone is JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES in?
In the 2025 upgraded edition of the CAS Journal Ranking, JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES?
The latest impact factor listed by LetPub is 5.3; CiteScore 8.8, h-index 69.
How long does peer review take at JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES?
Based on the dates recorded on 50 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 96 days (interquartile range 79–134 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES?
According to the journal's author guidelines: Keywords: ≥ 5; Reference style: Vancouver. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES based?
Of the 42 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (19), Canada (16) and United Kingdom (4). Counted from the institutions listed on the board page; for reference only.
Which databases index JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES?
According to LetPub and DOAJ records, JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, MEDLINE, PMC and CAB Abstracts; that list has not been checked against each database.
Is JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES open access, and what is the APC?
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES is a fully open-access journal. APC about USD 2,200.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .